Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CDER’s 50 Open Leadership Posts Could Be Bigger Hiring Challenges After Trump Freeze

Executive Summary

President Trump’s hiring freeze on civilian employees will exacerbate the Center for Drugs Evaluation & Research’s existing difficulties in recruiting and retaining qualified individuals. CDER is currently 591 positions under the hiring ceiling, include 50 open positions within CDER management.

Advertisement

Related Content

US FDA Still Waiting For Cures Money, Woodcock Says
US FDA Faces Hiring Slowdown, Funding Cuts In Trump's FY 17 Plan
US FDA May Find Relief From Trump's Hiring Freeze
Trump Promises Changes To 'A Lot Of Rules' At US FDA
A Burning FDA Hiring Freeze Question: What About User Fee-Supported Staff?
Trump Meets With Two US FDA Commissioner Candidates; Third Still Lurking
Oncology In 21st Century Cures: Heading Toward A Two-FDA Solution?
Woodcock, Califf Give Thumbs Up To Certain 21st Century Cures Provisions
'Brilliant' and 'Steady' Jenkins Retiring From US FDA's Office of New Drugs
CDER Pharmaceutical Quality Office Gains Permanent Director

Topics

Advertisement
UsernamePublicRestriction

Register

PS119968

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel